<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.bmjopen-2019-036727.pdfbmjopen-2019-036727.reviewer_comments.pdfbmjopen-2019-036727.draft_revisions.pdf Abstract Objectives" exact="Hepatitis" post="A incidence in Korea has dramatically increased in recent"/>
 <result pre="majority of the workforce in Korea, are particularly susceptible to" exact="infection" post="owing to a low seroprevalence of anti-hepatitis A virus"/>
 <result pre="Workers in formal employment having an annual routine health screening." exact="Primary" post="outcome measure Anti-HAV IgG seropositivity. Results Of 131 711 individuals"/>
 <result pre="years (vs 20–29 years, OR 2.51, 95% CI 2.36 to 2.68);" exact="female" post="sex (OR 1.54, 95% CI 1.48 to 1.59); experience of"/>
 <result pre="(OR 1.54, 95% CI 1.48 to 1.59); experience of any general" exact="disease" post="(vs no general disease history, OR 1.19, 95% CI 1.14"/>
 <result pre="to 1.59); experience of any general disease (vs no general" exact="disease" post="history, OR 1.19, 95% CI 1.14 to 1.25), obesity (vs"/>
 <result pre="no general disease history, OR 1.19, 95% CI 1.14 to 1.25)," exact="obesity" post="(vs normal weight, OR 0.91, 95% CI 0.86 to 0.97);"/>
 <result pre="(vs normal weight, OR 0.91, 95% CI 0.86 to 0.97); and" exact="hepatitis" post="B antibody seropositivity (OR 2.39, 95% CI 2.31 to 2.49)."/>
 <result pre="IgG seropositivity points to a need for implementation of workplace-based" exact="hepatitis" post="A vaccine programmes. To promote workers’ health and prevent"/>
 <result pre="hepatitis A vaccine programmes. To promote workers’ health and prevent" exact="hepatitis" post="A outbreaks, occupational health managers, healthcare providers and policy-makers"/>
 <result pre="difficult to determine causal interference. Background According to the WHO," exact="hepatitis" post="A caused an estimated 7134 deaths in 2016. Hepatitis"/>
 <result pre="WHO, hepatitis A caused an estimated 7134 deaths in 2016." exact="Hepatitis" post="A is a viral liver disease caused by hepatitis"/>
 <result pre="an estimated 7134 deaths in 2016. Hepatitis A is a" exact="viral" post="liver disease caused by hepatitis A virus (HAV). Globally,"/>
 <result pre="estimated 7134 deaths in 2016. Hepatitis A is a viral" exact="liver disease" post="caused by hepatitis A virus (HAV). Globally, HAV infection"/>
 <result pre="7134 deaths in 2016. Hepatitis A is a viral liver" exact="disease" post="caused by hepatitis A virus (HAV). Globally, HAV infection"/>
 <result pre="2016. Hepatitis A is a viral liver disease caused by" exact="hepatitis" post="A virus (HAV). Globally, HAV infection occurs sporadically and"/>
 <result pre="liver disease caused by hepatitis A virus (HAV). Globally, HAV" exact="infection" post="occurs sporadically and as outbreaks. It is estimated that"/>
 <result pre="is susceptible to HAV infection.2 There were 14 214 cases of" exact="hepatitis" post="A reported to the Korea Centers for Disease Control"/>
 <result pre="cases of hepatitis A reported to the Korea Centers for" exact="Disease" post="Control and Prevention (KCDC) from 1 January to 6"/>
 <result pre="period in 2018. KCDC attributed this increased incidence to the" exact="consumption" post="of contaminated salted clam products and weak herd immunity"/>
 <result pre="is ingested (fecal-oral route) and via direct contact with an" exact="infectious" post="person. Therefore, to prevent disease transmission, personal hygiene practices"/>
 <result pre="via direct contact with an infectious person. Therefore, to prevent" exact="disease" post="transmission, personal hygiene practices are very important. In addition,"/>
 <result pre="be considered as a high priority. Immunity against HAV is" exact="acquired" post="after complete recovery from acute hepatitis A and when"/>
 <result pre="as a high priority. Immunity against HAV is acquired after" exact="complete" post="recovery from acute hepatitis A and when properly vaccinated."/>
 <result pre="priority. Immunity against HAV is acquired after complete recovery from" exact="acute hepatitis" post="A and when properly vaccinated. Notwithstanding its relatively low"/>
 <result pre="Immunity against HAV is acquired after complete recovery from acute" exact="hepatitis" post="A and when properly vaccinated. Notwithstanding its relatively low"/>
 <result pre="not measure their waist circumference (n=775); and those with unmeasured" exact="total" post="cholesterol (n=16). We included the remaining 68 612 workers in"/>
 <result pre="(figure 1). Figure 1 Flow chart of participant selection. HAV," exact="hepatitis" post="A virus; IgG, immunoglobulin G. Measurement of variables Data"/>
 <result pre="variables Data on age, sex, area of residence, occupation, general" exact="disease" post="history, blood pressure, body mass index (BMI), waist circumference,"/>
 <result pre="blood pressure, body mass index (BMI), waist circumference, fasting glucose," exact="total" post="cholesterol, presence of hepatitis B surface antibody (HBsAb) and"/>
 <result pre="index (BMI), waist circumference, fasting glucose, total cholesterol, presence of" exact="hepatitis" post="B surface antibody (HBsAb) and anti-HAV IgG measured by"/>
 <result pre="measured by automated chemiluminescence immunoassay were extracted from clinical records." exact="General" post="disease history such as stroke, cardiac disease, hypertension, diabetes,"/>
 <result pre="by automated chemiluminescence immunoassay were extracted from clinical records. General" exact="disease" post="history such as stroke, cardiac disease, hypertension, diabetes, cancer,"/>
 <result pre="extracted from clinical records. General disease history such as stroke," exact="cardiac disease," post="hypertension, diabetes, cancer, pulmonary tuberculosis, dyslipidaemia and any chronic"/>
 <result pre="disease history such as stroke, cardiac disease, hypertension, diabetes, cancer," exact="pulmonary tuberculosis," post="dyslipidaemia and any chronic or acute disease history were"/>
 <result pre="cardiac disease, hypertension, diabetes, cancer, pulmonary tuberculosis, dyslipidaemia and any" exact="chronic" post="or acute disease history were obtained through a doctor’s"/>
 <result pre="hypertension, diabetes, cancer, pulmonary tuberculosis, dyslipidaemia and any chronic or" exact="acute" post="disease history were obtained through a doctor’s face-to-face interview"/>
 <result pre="diabetes, cancer, pulmonary tuberculosis, dyslipidaemia and any chronic or acute" exact="disease" post="history were obtained through a doctor’s face-to-face interview during"/>
 <result pre="blood samples collected from antecubital vein after ≥12 hours of fasting." exact="Blood" post="pressure was classified according to the Eighth Report of"/>
 <result pre="pressure was classified according to the Eighth Report of the" exact="Joint" post="National Committee on Prevention.5 BMI was divided into three"/>
 <result pre="three categories: normal, &amp;lt;25 kg/m2; overweight, 25–29.9 kg/m2; and obese, ≥30 kg/m2. Abdominal" exact="obesity" post="was defined by waist circumference:&amp;gt;90 cm for men and &amp;gt;85 cm"/>
 <result pre="by waist circumference:&amp;gt;90 cm for men and &amp;gt;85 cm for women. Normal," exact="glucose intolerance" post="and suspected diabetes were defined as a fasting blood"/>
 <result pre="men and &amp;gt;85 cm for women. Normal, glucose intolerance and suspected" exact="diabetes" post="were defined as a fasting blood glucose level &amp;lt;100 mg/dL,"/>
 <result pre="fasting blood glucose level &amp;lt;100 mg/dL, 100–125 mg/dL and ≥126 mg/dL, respectively. A" exact="total" post="cholesterol level ≥240 mg/dL was considered to be elevated. In"/>
 <result pre="of Seoul. The participants were relatively healthy: 12.6% had a" exact="disease" post="history. The prevalence of hypertension, obesity, diabetes and dyslipidaemia"/>
 <result pre="12.6% had a disease history. The prevalence of hypertension, obesity," exact="diabetes" post="and dyslipidaemia was 4.2%, 7.2%, 1.1% and 6.1%, respectively,"/>
 <result pre="HBsAb positive. None of the participants reported a history of" exact="hepatitis" post="A. The overall seroprevalence of anti-HAV IgG (hereinafter seroprevalence)"/>
 <result pre="and it differed significantly by sex, age, area of residence," exact="disease" post="history, blood pressure, BMI, total cholesterol level, fasting blood"/>
 <result pre="sex, age, area of residence, disease history, blood pressure, BMI," exact="total" post="cholesterol level, fasting blood glucose level and HBsAb status"/>
 <result pre="(HAV) immunoglobulin G (IgG) by participant demographic and clinical characteristics" exact="Total" post="IgG anti-HAV (+) IgG anti-HAV (−) P value N"/>
 <result pre=" Other regions, n (%) 10 956 (23.8) 4062 (37.1) 6894 (62.9)" exact="Disease" post="history (any)  No, n (%) 59 951 (87.4) 21 105 (35.2)"/>
 <result pre="&amp;lt;0.001  Yes, n (%) 8661 (12.6) 3766 (43.5) 4895 (56.5)" exact="Blood" post="pressure (mm Hg)  Normal, n (%) 31 733 (46.2) 12 193"/>
 <result pre=" Suspected diabetes, n (%) 725 (1.1) 288 (39.7) 437 (60.3)" exact="Total" post="cholesterol (mg/dL), median (IQR) 187 (165–207) 187 (165–207) 187"/>
 <result pre="(66.3) 19 772 (43.5) 25 729 (56.5) BMI, body mass index; HAV," exact="hepatitis" post="A virus; HBsAb, hepatitis B surface antibody; IgG, immunoglobulin"/>
 <result pre="(56.5) BMI, body mass index; HAV, hepatitis A virus; HBsAb," exact="hepatitis" post="B surface antibody; IgG, immunoglobulin G; IQR, interquartile range."/>
 <result pre="immunoglobulin G (IgG) and occupational characteristics of the study participants" exact="Total" post="IgG anti-HAV (+) IgG anti-HAV (−) P value Occupational"/>
 <result pre="(64.2) *Occupational classifications with &amp;lt;50 workers are not shown. HAV," exact="hepatitis" post="A virus; IgG, immunoglobulin G. Factors associated with the"/>
 <result pre="In the fully adjusted logistic regression model, age, sex, BMI," exact="disease" post="history, hepatitis B status, occupational classification and number of"/>
 <result pre="fully adjusted logistic regression model, age, sex, BMI, disease history," exact="hepatitis" post="B status, occupational classification and number of workplace health"/>
 <result pre="years (vs 20–29 years, OR 2.51, 95% CI 2.36 to 2.68);" exact="female" post="sex (OR 1.54, 95% CI 1.48 to 1.59); and hepatitis"/>
 <result pre="2.68); female sex (OR 1.54, 95% CI 1.48 to 1.59); and" exact="hepatitis" post="B antibody seropositivity (OR 2.39, 95% CI 2.31 to 2.49)"/>
 <result pre="1.08 (1.03 to 1.13)  Seoul city 1.41 (1.32 to 1.49)" exact="Disease" post="history (any)  No 1.00 (reference) 1.00 (reference)  Yes 1.42"/>
 <result pre="(reference)  Yes 1.42 (1.35 to 1.48) 1.19 (1.14 to 1.25)" exact="Blood" post="pressure  Normal 1.00 (reference)  Prehypertension 0.84 (0.81 to 0.87)"/>
 <result pre="0.91 (0.86 to 0.97) Waist circumference  Normal 1.00 (reference)  Abdominal" exact="obesity" post="0.94 (0.90 to 0.98) Fasting glucose  Normal 1.00 (reference)"/>
 <result pre=" Normal 1.00 (reference)  Glucose intolerance 1.04 (1.00 to 1.09)  Suspected" exact="diabetes" post="1.17 (1.01 to 1.36) Total cholesterol  Normal 1.00 (reference)"/>
 <result pre="1.04 (1.00 to 1.09)  Suspected diabetes 1.17 (1.01 to 1.36)" exact="Total" post="cholesterol  Normal 1.00 (reference)  Elevated 1.08 (1.01 to 1.15)"/>
 <result pre="values. †P for trend &amp;lt;0.001. BMI, body mass index; HBsAb," exact="hepatitis" post="B surface antibody. Discussion Principal findings The overall seroprevalence"/>
 <result pre="with age. Men and those living outside Seoul had a" exact="lower" post="seroprevalence than women and those living in Seoul, respectively,"/>
 <result pre="to WHO in 2009, the estimated prevalence of immunity against" exact="hepatitis" post="A in Korea increased with age, from 25% among"/>
 <result pre="to the decrease in exposure to the HAV of the" exact="lower" post="age groups due to the high economic growth and"/>
 <result pre="to better access to medical care in Seoul so that" exact="lower" post="barriers to health behaviour; however, the National Health and"/>
 <result pre="to vaccination behaviours as well as medication adherence, management of" exact="hypertension" post="and hyperlipidaemia, and dysfunctional health beliefs about obesity,10 although"/>
 <result pre="studies have directly proved the relationship between personal behaviour and" exact="hepatitis" post="A vaccination yet. Indeed, anti-HAV seroprevalence differed significantly by"/>
 <result pre="hepatitis A vaccination yet. Indeed, anti-HAV seroprevalence differed significantly by" exact="disease" post="history, blood pressure, BMI, waist circumference, total cholesterol level"/>
 <result pre="differed significantly by disease history, blood pressure, BMI, waist circumference," exact="total" post="cholesterol level and fasting blood glucose, suggesting that these"/>
 <result pre="vaccination rather than clinical or pathological mechanism and among them," exact="disease" post="history and BMI were significantly associated even after adjustment."/>
 <result pre="need for further longitudinal studies. Second, it was unknown whether" exact="hepatitis" post="A IgG antibody seropositivity of participants was acquired by"/>
 <result pre="unknown whether hepatitis A IgG antibody seropositivity of participants was" exact="acquired" post="by vaccination or past infection because of the absence"/>
 <result pre="antibody seropositivity of participants was acquired by vaccination or past" exact="infection" post="because of the absence of records on vaccination history"/>
 <result pre="was acquired by vaccination or past infection because of the" exact="absence of" post="records on vaccination history in our study. Third, demographic"/>
 <result pre="region, 1990 and 2005. Vaccine2010;28:6653–7. 10.1016/j.vaccine.2010.08.03720723630 3collab: Korea Centers for" exact="Disease" post="Control and PreventionIn-Depth epidemiologic survey results for hepatitis A"/>
 <result pre="Centers for Disease Control and PreventionIn-Depth epidemiologic survey results for" exact="hepatitis" post="A outbreaks in 2019. Available: https://www.cdc.go.kr/board.es?mid=a20501000000&amp;amp;bid=0015&amp;amp;act=view&amp;amp;list_no=364837# [Accessed 14 Oct"/>
 <result pre="of Health and Welfare of Korea, collab: Korea centers for" exact="Disease" post="Control and Prevention&quot;Korea health statics 2015: Korea national health"/>
 <result pre="OparilS, CarterBL, et al.2014 evidence-based guideline for the management of" exact="high blood pressure" post="in adults: report from the panel members appointed to"/>
 <result pre="8). JAMA2014;311:507–20. 10.1001/jama.2013.28442724352797 6collab: World Health OrganisationThe global prevalence of" exact="hepatitis" post="A virus infection and susceptibility: a systematic review. Available:"/>
 <result pre="10.1001/jama.2013.28442724352797 6collab: World Health OrganisationThe global prevalence of hepatitis A" exact="virus infection" post="and susceptibility: a systematic review. Available: https://apps.who.int/iris/bitstream/handle/10665/70180/WHO_IVB_10.01_eng.pdf;jsessionid=27EB41E8CC0BC37AC1D62079EDC5C1F4?sequence=1 [Accessed 14"/>
 <result pre="6collab: World Health OrganisationThe global prevalence of hepatitis A virus" exact="infection" post="and susceptibility: a systematic review. Available: https://apps.who.int/iris/bitstream/handle/10665/70180/WHO_IVB_10.01_eng.pdf;jsessionid=27EB41E8CC0BC37AC1D62079EDC5C1F4?sequence=1 [Accessed 14"/>
 <result pre="of Health and Welfare of Korea, collab: Korea centers for" exact="Disease" post="Control and Prevention&quot;Korea health statics 2017: Korea national health"/>
 <result pre="Trop Med Hyg2015;109:9–15. 10.1093/trstmh/tru16725573105 9YunH, LeeH-J, CheonD, et al.Seroprevalence of" exact="hepatitis" post="A and E viruses based on the third Korea"/>
 <result pre="Perspect2011;2:46–50. 10.1016/j.phrp.2011.04.00924159450 10LongE, PonderM, BernardSKnowledge, attitudes, and beliefs related to" exact="hypertension" post="and hyperlipidemia self-management among African-American men living in the"/>
 <result pre="10LongE, PonderM, BernardSKnowledge, attitudes, and beliefs related to hypertension and" exact="hyperlipidemia" post="self-management among African-American men living in the southeastern United"/>
</results>
